Navigation Links
CDC Study Links Thimerosal in Vaccines to Motor/Phonic Tics and Deficits in Attention, Behavior Control, Verbal IQ
Date:9/26/2007

Study's conclusion of no causal link disputes its own data while several authors' ties to vaccine/pharma defendants spotlight conflicts of interest

NIXA, Mo., Sept. 26 /PRNewswire-USNewswire/ -- The National Autism Association (NAA) says that a CDC study of only 1047 participants, low compliance rate, and very little data variation -- limitations that would ordinarily bar publication in any reputable journal -- appears to misinform the public. They question how such a poor quality study and misleading conclusion can be published in the New England Journal of Medicine (NEJM).

The research conclusion states that findings couldn't support a causal association between early exposure to mercury from thimerosal-containing vaccines and neuropsychological functioning. Yet the data in the body of the paper clearly states a statistically significant relationship between thimerosal and a host of co-morbid disorders frequently seen in autism, replicating earlier CDC findings published in the Nov. 2003 journal Pediatrics.

Contradicting its own conclusion, the NEJM paper states (pgs. 1284-85, 1290) that higher exposure to mercury was associated with:

-- significantly poorer performance on tests of backward recall

-- behavioral regulation problems and a higher likelihood of motor and

phonic tics

-- lower verbal IQ scores

-- speech articulation problems

The study's interpretive outcome and favorable results towards the CDC and vaccine makers might be explained by the exhaustive list of conflicts of interests disclosed by study authors (pg. 1291). "The CDC sets vaccine policy and has ties to vaccine makers, lending bias to any studies they conduct regarding potential vaccine injuries," said NAA board member Scott Bono. "How can Americans expect them to rule against their own policy that advocates injecting excess amounts of a known neurotoxin into children?"

Also, NAA believes that the low compliance rate of 30%, starkly lower than the usual 70% rate in scientific research, might reflect public distrust of the CDC and vaccine safety.

Sallie Bernard, co-founder and executive director of SafeMinds, is a dissenting panel member and the only consumer representative of the study. More commentary on the study can be found at http://www.safeminds.org. To read the study, go to http://www.nejm.org.

Some vaccines and most flu shots still contain a toxic mix of mercury and aluminum.

For more information about autism, go to http://www.nationalautism.org.

Contact: Wendy Fournier

401-632-7523

Rita Shreffler

401-632-6452


'/>"/>
SOURCE National Autism Association
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Rural Canadians travel far for specialists: study
2. A new study surpasses Gene Therapy Hurdle
3. Tomato Sauce reduces Cancer Risk- Study
4. A question on study of Adult Stem Cell
5. Study on obesity and heart failure
6. National Lung Study in the process
7. Marijuana gateway theory strengthened by study of twins
8. Old theory of adaptation confirmed by new study
9. Study casts doubt on keyboard ills
10. Gene study links endometriosis, infertility
11. Study reveals how stress can make you sick
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... ... March 27, 2017 , ... M&S ... Certificate of Conformity for the Smart System® 20/20. CE Certification builds upon M&S's ... standards and specifications such as ANSI, ISO and proven test methods used in ...
(Date:3/27/2017)... PA (PRWEB) , ... March 27, 2017 , ... ... business simulation -centric training, today announced the launch of a new research ... strategy, having the skills needed to execute that strategy, and the actual success ...
(Date:3/27/2017)... ... March 27, 2017 , ... According to the American Cancer ... stages, is more than 95%. Once the cancer spreads to other organs, bones, or ... find out how to avoid this latter group, tune in to Lifestyle Magazine ...
(Date:3/27/2017)... Texas (PRWEB) , ... March 27, 2017 , ... ... at the GTEC Orange facility from 8:00am-10:00am on Monday, April 3rd to commemorate ... and will be an opportunity for area-residents to celebrate two great years while ...
(Date:3/25/2017)... PA (PRWEB) , ... March 25, 2017 , ... Getting ... as a public relations partner. , All through the year, Garden Media aims ... press releases, working with key influencers and pitching client’s key messages to ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... , March 27, 2017  ImMAGE Biotherapeutics (OTCMKTS: ... immunotherapy successfully passed early toxicology and efficacy studies. The ... to target a specific protein, MAGE A, in an ... breast cancer. After 4 weeks of ... to show very little toxicity in a full toxicology ...
(Date:3/27/2017)... , March 27, 2017  Sanderling Ventures, portfolio ... Ethicon, a division of Johnson & Johnson. Torax manufactures ... the treatment of gastro-esophageal reflux disease (GERD). The ... (MSA) technology and the procedure is currently available ... Torax Medical was founded by Sanderling Ventures, ...
(Date:3/27/2017)... TEL AVIV, Israel , March 27, 2017 ... focused on oncology and immunology, announced today that AGI-134, an ... recently announced acquisition of Agalimmune Ltd., will be featured at ... Meeting in Washington, DC to ... ...
Breaking Medicine Technology: